Skip Navigation
CNBC
Markets
  • Pre-Markets
  • U.S. Markets
  • Currencies
  • Prediction Markets
  • Cryptocurrency
  • Futures & Commodities
  • Bonds
  • Funds & ETFs
Business
  • Economy
  • Finance
  • Health & Science
  • Media
  • Real Estate
  • Energy
  • Climate
  • Transportation
  • Investigations
  • Industrials
  • Retail
  • Wealth
  • Sports
  • Life
  • Small Business
Investing
  • Personal Finance
  • Fintech
  • Financial Advisors
  • Options Action
  • ETF Street
  • Buffett Archive
  • Earnings
  • Trader Talk
Tech
  • Cybersecurity
  • AI
  • Enterprise
  • Internet
  • Media
  • Mobile
  • Social Media
  • CNBC Disruptor 50
  • Tech Guide
Politics
  • White House
  • Policy
  • Defense
  • Congress
  • Expanding Opportunity
Video
  • Latest Video
  • Full Episodes
  • Livestream
  • Live Audio
  • Live TV Schedule
  • CNBC Podcasts
  • CEO Interviews
  • CNBC Documentaries
  • Digital Originals
Watchlist
Investing Club
  • Trust Portfolio
  • Analysis
  • Trade Alerts
  • Meeting Videos
  • Homestretch
  • Jim's Columns
  • Education
  • Subscribe
Join IC
PRO
  • Pro News
  • Josh Brown
  • Mike Santoli
  • Calls of the Day
  • My Portfolio
  • Livestream
  • Full Episodes
  • Stock Screener
  • Market Forecast
  • Options Investing
  • Chart Investing
  • Subscribe
Join Pro
Livestream
  • Make It
  • select
  • USA
  • INTL
  • Livestream
  • Livestream
Watchlist
SIGN IN
Create free account
Markets
Business
Investing
Tech
Politics
Video
Watchlist
Investing Club
Join IC
PRO
Join Pro
Livestream

Elsa Ohlen

Elsa Ohlen

Elsa Ohlen is a companies reporter at CNBC International in London, covering earnings, strategy shifts, leadership changes, and industry trends.

Latest

Novo Nordisk shares tumble 18% as CEO warns it will get worse before it gets better
Elsa Ohlen7 Hours Ago
Novo Nordisk shares tumble after company warns of sales hit this year
Elsa Ohlen22 Hours Ago
The world’s largest jeweler is under pressure from the volatile silver price
Elsa OhlenFebruary 3, 2026
Why AstraZeneca poured billions into China ahead of Monday’s U.S. share listing
Elsa OhlenFebruary 1, 2026
Roche, Sanofi tout pharma pipelines as earnings fail to excite
Elsa OhlenJanuary 29, 2026
LVMH shares plummet nearly 8% as fourth-quarter results lag competitors
Elsa OhlenJanuary 28, 2026
LVMH beats earnings expectations as China recovery mounts
Elsa OhlenJanuary 27, 2026
Puma shares surge after Anta Sports buys stake for $1.8 billion amid turnaround efforts
Anniek Bao|Elsa OhlenJanuary 27, 2026
watch now
VIDEO01:51
Big pharma eyes M&A spree, spurred by patent cliff
Elsa OhlenJanuary 12, 2026
Europe's best-performing blue-chip stock has become a prime takeover target
Elsa OhlenJanuary 9, 2026
Rolls-Royce has hit a record high every trading day of 2026. Here's why
Elsa OhlenJanuary 9, 2026
Big Pharma race to snap up biotech assets as $170 billion patent cliff looms
Elsa OhlenJanuary 7, 2026
CNBC logo
  • Subscribe to CNBC PRO
  • Subscribe to Investing Club
  • Licensing & Reprints
  • CNBC Councils
  • Select Personal Finance
  • Join the CNBC Panel
  • Closed Captioning
  • Digital Products
  • News Releases
  • Internships
  • Corrections
  • About CNBC
  • Site Map
  • Podcasts
  • Careers
  • Help
  • Contact
  • News Tips

    Got a confidential news tip? We want to hear from you.

    Get In Touch
  • CNBC Newsletters

    Sign up for free newsletters and get more CNBC delivered to your inbox

    Sign Up Now

    Get this delivered to your inbox, and more info about our products and services.

  • Advertise With Us

    Please Contact Us
  • Ad Choices
  • Privacy Policy
  • California Consumer Privacy Act (CCPA) Opt-Out IconYour Privacy Choices
  • CA Notice
  • Terms of Service

© 2026 Versant Media, LLC. All Rights Reserved. A Versant Media Company.

Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.

Market Data Terms of Use and Disclaimers

Data also provided byReuters logo